東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cancer chemotherapy, immunotherapy, ...

Chabner, Bruce A.

FindBook

Google Book

Amazon

博客來

Cancer chemotherapy, immunotherapy, and biotherapy = principles and practice /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cancer chemotherapy, immunotherapy, and biotherapy/ edited by Bruce A. Chabner, Dan L. Longo.
其他題名:	principles and practice /
其他作者:	Chabner, Bruce A.
出版者:	Philadelphia :Lippincott Williams & Wilkins, : 2019.,
面頁冊數:	1 online resource (xii, 656 p.) :ill.
附註:	Preceded by Cancer chemotherapy and biotherapy : principles and practice / editors, Bruce A. Chabner, Dan L. Longo. 5th ed. 2011.
內容註:	I: Basic principles of cancer treatment -- Clinical strategies for cancer treatment: the role of drugs -- Target identification and drug discovery -- Clinical drug development and approval -- Principles of pharmacokinetics -- Pharmacogenomics and the role of genomics in cancer therapeutics -- Delivering anticancer drugs to brain tumors -- Antifolates -- 5-Fluoropyrimidines -- Cytidine analogues -- Purine analogs -- Antimitotic drugs -- Alkylating and methylating agents -- Platinum analogues -- Topoisomerase inhibitors -- Bleomycin, yondelis, MMC -- Epigenetic agents in oncology : HDAC inhibitors, IDH inhibitors, and EZH2 inhibitors -- Differentiating agents -- Asparaginase -- II: Targeted agents -- Proteasome inhibitors -- Thalidomide and its analogs in the treatment of hematologic malignancies, including multiple myeloma, and solid tumors -- Targeted therapy in non-small cell lung cancer -- MAP kinase pathway -- CDK inhibitors -- Drugs targeting the ABL and JAK kinases -- The PI3K/AKT/mTOR signaling system -- Inhibitors of tumor angiogenesis -- III: Hormone antagonists -- Endocrine therapy of breast cancer -- Hormone therapy for prostate cancer -- IV: Immune-based therapies -- Monoclonal antibodies -- Cytokine therapy for cancer -- Adoptive cellular therapy -- V: Supportive care -- Antiemetics -- Hematopoietic growth factors -- Cancer and coagulopathy.
標題:	Cancer - Chemotherapy. -
電子資源:	http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=booktext&D=books&AN=02070855/6th_Edition&XPATH=/PG(0)&EPUB=N

Cancer chemotherapy, immunotherapy, and biotherapy = principles and practice /
Cancer chemotherapy and biotherapy.

Cancer chemotherapy, immunotherapy, and biotherapyprinciples and practice /[electronic resource] :edited by Bruce A. Chabner, Dan L. Longo. - 6th ed. - Philadelphia :Lippincott Williams & Wilkins,2019. - 1 online resource (xii, 656 p.) :ill.

Preceded by Cancer chemotherapy and biotherapy : principles and practice / editors, Bruce A. Chabner, Dan L. Longo. 5th ed. 2011.

Includes bibliographical references and index.

I: Basic principles of cancer treatment -- Clinical strategies for cancer treatment: the role of drugs -- Target identification and drug discovery -- Clinical drug development and approval -- Principles of pharmacokinetics -- Pharmacogenomics and the role of genomics in cancer therapeutics -- Delivering anticancer drugs to brain tumors -- Antifolates -- 5-Fluoropyrimidines -- Cytidine analogues -- Purine analogs -- Antimitotic drugs -- Alkylating and methylating agents -- Platinum analogues -- Topoisomerase inhibitors -- Bleomycin, yondelis, MMC -- Epigenetic agents in oncology : HDAC inhibitors, IDH inhibitors, and EZH2 inhibitors -- Differentiating agents -- Asparaginase -- II: Targeted agents -- Proteasome inhibitors -- Thalidomide and its analogs in the treatment of hematologic malignancies, including multiple myeloma, and solid tumors -- Targeted therapy in non-small cell lung cancer -- MAP kinase pathway -- CDK inhibitors -- Drugs targeting the ABL and JAK kinases -- The PI3K/AKT/mTOR signaling system -- Inhibitors of tumor angiogenesis -- III: Hormone antagonists -- Endocrine therapy of breast cancer -- Hormone therapy for prostate cancer -- IV: Immune-based therapies -- Monoclonal antibodies -- Cytokine therapy for cancer -- Adoptive cellular therapy -- V: Supportive care -- Antiemetics -- Hematopoietic growth factors -- Cancer and coagulopathy.

Electronic reproduction.
New York, N.Y. :
Ovid Technologies, Inc.

Available via World Wide Web.

LCCN: 2018022251Subjects--Topical Terms:

753516
Cancer
--Chemotherapy.

LC Class. No.: RC271.C5 / C32219 2019

Dewey Class. No.: 616.994061

National Library of Medicine Call No.: QZ267 / C21515 2019

Cancer chemotherapy, immunotherapy, and biotherapy = principles and practice /
LDR:02814cmm a2200325 i 4500 001 2212007
005 20191107152426.0
006 m o d
007 cr cnu---unuuu
008 201107s2019 paua ob 001 0 eng d
010 $a 2018022251
020 $z 9781496375148
020 $z 1496375149
035 $a (OCoLC)1035402585 $z (OCoLC)1020310971 $z (OCoLC)1055210475
035 $a (OCoLC)on1035402585
035 $a 1038585982504786
040 $a NLM $b eng $c NLM $d YDX $d DLC $d TKN $d OCLCF $d NLM $d OCLCO $d CULIB $d UKMGB $d VVL $d SMV $d OCLCQ $d OCLCO $d OCLCQ
041 0 $a eng
050 0 0 $a RC271.C5 $b C32219 2019
060 4 $a QZ267 $b C21515 2019
082 0 0 $a 616.994061 $2 23
130 0 $a Cancer chemotherapy and biotherapy. $3 3439990
245 1 0 $a Cancer chemotherapy, immunotherapy, and biotherapy $h [electronic resource] : $b principles and practice / $c edited by Bruce A. Chabner, Dan L. Longo.
250 $a 6th ed.
260 $a Philadelphia : $b Lippincott Williams & Wilkins, $c 2019.
300 $a 1 online resource (xii, 656 p.) : $b ill.
500 $a Preceded by Cancer chemotherapy and biotherapy : principles and practice / editors, Bruce A. Chabner, Dan L. Longo. 5th ed. 2011.
504 $a Includes bibliographical references and index.
505 0 $a I: Basic principles of cancer treatment -- Clinical strategies for cancer treatment: the role of drugs -- Target identification and drug discovery -- Clinical drug development and approval -- Principles of pharmacokinetics -- Pharmacogenomics and the role of genomics in cancer therapeutics -- Delivering anticancer drugs to brain tumors -- Antifolates -- 5-Fluoropyrimidines -- Cytidine analogues -- Purine analogs -- Antimitotic drugs -- Alkylating and methylating agents -- Platinum analogues -- Topoisomerase inhibitors -- Bleomycin, yondelis, MMC -- Epigenetic agents in oncology : HDAC inhibitors, IDH inhibitors, and EZH2 inhibitors -- Differentiating agents -- Asparaginase -- II: Targeted agents -- Proteasome inhibitors -- Thalidomide and its analogs in the treatment of hematologic malignancies, including multiple myeloma, and solid tumors -- Targeted therapy in non-small cell lung cancer -- MAP kinase pathway -- CDK inhibitors -- Drugs targeting the ABL and JAK kinases -- The PI3K/AKT/mTOR signaling system -- Inhibitors of tumor angiogenesis -- III: Hormone antagonists -- Endocrine therapy of breast cancer -- Hormone therapy for prostate cancer -- IV: Immune-based therapies -- Monoclonal antibodies -- Cytokine therapy for cancer -- Adoptive cellular therapy -- V: Supportive care -- Antiemetics -- Hematopoietic growth factors -- Cancer and coagulopathy.
533 $a Electronic reproduction. $b New York, N.Y. : $c Ovid Technologies, Inc. $n Available via World Wide Web.
588 $a Description based on print version record.
650 0 $a Cancer $x Chemotherapy. $3 753516
650 0 $a Cancer $x Immunotherapy. $3 656051
650 0 $a Antineoplastic agents. $3 795427
650 0 $a Biological response modifiers. $3 662992
650 1 2 $a Neoplasms $x drug therapy. $3 835915
650 2 2 $a Antineoplastic Agents $x therapeutic use. $3 931450
650 2 2 $a Biological Products $x therapeutic use. $3 3303526
650 2 2 $a Neoplasms $x therapy. $3 616080
700 1 $a Chabner, Bruce A. $3 3439991
700 1 $a Longo, Dan L. $q (Dan Louis), $d 1949- $3 3439992
856 4 0 $u http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=booktext&D=books&AN=02070855/6th_Edition&XPATH=/PG(0)&EPUB=N